Dubai Telegraph - First Covid vaccine side-effect claims land in German courts

EUR -
AED 4.294321
AFN 74.253619
ALL 95.872296
AMD 433.704387
ANG 2.092944
AOA 1073.434204
ARS 1639.383876
AUD 1.630848
AWG 2.107696
AZN 1.96015
BAM 1.954468
BBD 2.355421
BDT 143.521562
BGN 1.950542
BHD 0.441304
BIF 3478.721029
BMD 1.169318
BND 1.491883
BOB 8.111471
BRL 5.829991
BSD 1.169468
BTN 111.167228
BWP 15.875179
BYN 3.307945
BYR 22918.632663
BZD 2.352497
CAD 1.592787
CDF 2708.140315
CHF 0.916739
CLF 0.027102
CLP 1066.675183
CNY 7.986734
CNH 7.98829
COP 4361.123466
CRC 531.735296
CUC 1.169318
CUP 30.986927
CVE 110.675798
CZK 24.396662
DJF 207.811219
DKK 7.472054
DOP 69.685287
DZD 154.832962
EGP 62.591601
ERN 17.53977
ETB 183.67067
FJD 2.57057
FKP 0.860877
GBP 0.864065
GEL 3.139597
GGP 0.860877
GHS 13.090504
GIP 0.860877
GMD 85.913622
GNF 10263.693503
GTQ 8.938111
GYD 244.683224
HKD 9.159616
HNL 31.138853
HRK 7.534738
HTG 153.054918
HUF 365.043672
IDR 20334.381433
ILS 3.442466
IMP 0.860877
INR 111.388823
IQD 1531.806571
IRR 1537653.160541
ISK 143.404954
JEP 0.860877
JMD 184.244419
JOD 0.829086
JPY 183.83781
KES 151.051793
KGS 102.222361
KHR 4691.303387
KMF 491.721159
KPW 1052.386191
KRW 1728.533127
KWD 0.360173
KYD 0.974736
KZT 542.540205
LAK 25681.144292
LBP 104538.465789
LKR 373.722075
LRD 214.716016
LSL 19.680048
LTL 3.452693
LVL 0.707309
LYD 7.407627
MAD 10.812674
MDL 20.136275
MGA 4858.516457
MKD 61.637266
MMK 2455.275164
MNT 4182.27105
MOP 9.437268
MRU 46.71434
MUR 54.676984
MVR 18.071781
MWK 2036.313487
MXN 20.481189
MYR 4.632873
MZN 74.731036
NAD 19.679919
NGN 1603.05293
NIO 42.937367
NOK 10.845132
NPR 177.865485
NZD 1.991121
OMR 0.449603
PAB 1.169703
PEN 4.099639
PGK 5.066072
PHP 72.252128
PKR 325.947045
PLN 4.258832
PYG 7271.044057
QAR 4.259828
RON 5.192473
RSD 117.386687
RUB 87.698649
RWF 1707.788929
SAR 4.387509
SBD 9.384792
SCR 16.054895
SDG 702.171763
SEK 10.866352
SGD 1.492989
SHP 0.873014
SLE 28.824094
SLL 24520.009172
SOS 668.263928
SRD 43.797951
STD 24202.521612
STN 24.731076
SVC 10.23498
SYP 129.238853
SZL 19.67902
THB 38.271563
TJS 10.948537
TMT 4.09846
TND 3.374069
TOP 2.815437
TRY 52.872586
TTD 7.944585
TWD 37.040504
TZS 3034.379932
UAH 51.538272
UGX 4389.126281
USD 1.169318
UYU 47.107891
UZS 14029.47757
VES 571.729555
VND 30799.251277
VUV 138.890167
WST 3.174919
XAF 655.510204
XAG 0.016054
XAU 0.000258
XCD 3.16014
XCG 2.108163
XDR 0.813413
XOF 653.066113
XPF 119.331742
YER 279.028522
ZAR 19.63192
ZMK 10525.262602
ZMW 21.903071
ZWL 376.519917
  • RBGPF

    0.5000

    63.1

    +0.79%

  • RELX

    0.0100

    36.36

    +0.03%

  • BTI

    -0.3600

    58.35

    -0.62%

  • CMSC

    -0.0100

    22.87

    -0.04%

  • GSK

    -0.7100

    50.9

    -1.39%

  • RIO

    -1.9500

    98.63

    -1.98%

  • BCE

    -0.0300

    23.93

    -0.13%

  • AZN

    -1.2800

    183.46

    -0.7%

  • CMSD

    -0.0300

    23.25

    -0.13%

  • NGG

    -0.9800

    87.5

    -1.12%

  • BP

    0.5300

    46.94

    +1.13%

  • JRI

    -0.0500

    12.93

    -0.39%

  • BCC

    -3.8000

    74.33

    -5.11%

  • RYCEF

    -0.3000

    16

    -1.88%

  • VOD

    -0.1000

    16.05

    -0.62%

First Covid vaccine side-effect claims land in German courts

First Covid vaccine side-effect claims land in German courts

Vaccine-maker BioNTech faced Monday its first legal claim in its home country of Germany over adverse effects allegedly suffered by some users of its Covid vaccines, more than two years after one of the world's fastest and most extensive inoculation campaigns.

Text size:

In the face of the deadly pandemic that emerged in early 2020, which prompted border closures and lockdowns that trapped millions of people in their homes, the arrival of Covid vaccines had been widely hailed as a life-saver.

But the jabs, which had been developed at breakneck speed and granted early approval for usage, are now the focus of legal procedures in several countries including France and Britain where plaintiffs argue that the vaccines harmed their health.

In Germany, a court in Hamburg was prepared to hear a case from Monday against BioNTech, which, together with US giant Pfizer, produced the first mRNA vaccine Comirnaty.

The hearing was delayed however after the claimant's lawyers put in a last-minute challenge of the judge's impartiality, and asking instead for a panel of judges to rule on the case.

In her claim, the plaintiff reported suffering effects including "pain in the upper body, swelling of the extremities, exhaustion, fatigue and sleeping disorders" after receiving the vaccine, the court said.

She is seeking 150,000 euros ($162,000) in damages and recognition that the "defendant is bound to provide material damages", the court added.

Her lawyer Thomas Ulbrich, who is also representing another 250 people in similar cases, said his clients were "all healthy" before suffering from symptoms, allegedly following their jabs.

He believes that the medical files he has on hand offer a link between the vaccines and the symptoms experienced by his clients.

- 'Rocky and long road' -

BioNTech's mRNA vaccine, a scientific breakthrough, had been granted conditional marketing authorisation as early as December 21, 2020, by the EU regulatory authority EMA.

Similar authorisation for Moderna, another mRNA vaccine maker, swiftly followed.

With fears of catching the disease running high, the vaccines were pre-ordered by governments even during their development phases, and deployment swiftly followed once regulatory authorities gave their approval.

But the new generation of inoculations also sparked a wave of vaccine sceptics questioning the safety of the jabs.

Out of 192 million jabs given in Germany, the country's medicines regulator, the Paul Ehrlich Institute, said 338,857 suspected cases of side effects were reported, including 54,879 severe reactions.

Among the worst cases, "the symptoms are very different, they vary from stroke to thrombosis to cardiac diseases", said another German lawyer, Joachim Caesar-Preller, who represents 140 clients making similar claims.

He is seeking up to one million euros in damages per case -- plus interest -- but concedes that a "rocky and long road" lies ahead in the legal battles.

- 'Not an isolated case' -

A key point for the courts is whether the side effects of the medication, when used correctly, surpass "a justifiable level according to the findings of medical science".

In other words, the effects have to be sufficiently serious to be taken into account, said Anatol Dutta, a professor at Munich University.

A claimant identified only as Kathrin K., 45, believes her symptoms are severe enough.

She said she lost a lot of weight after taking the vaccine and had to undergo several intestinal operations.

"I hate it when people tell me that I'm an isolated case," she said. "I'm not."

To address the question of causality, the courts would likely have to obtain expert advice.

Besides the legal avenue, claimants can also turn to the state for compensation for the loss of income.

More than 8,000 such applications had been made as of April, and so far about five percent have been successful, according to German media.

BioNTech told AFP that the number of liability claims made to the company is very small when compared to the number of doses it has delivered worldwide, and that each claim had to be examined individually.

"Justified liability claims would of course be met by BioNTech," it said, adding however that "no causal relationship between (the) health impairments presented and vaccination with Comirnaty has been proven" in the cases it had reviewed so far.

Another lawyer, Anja Dornhoff, advises her clients to establish a chronology and to get medical practitioners to document the development of their symptoms.

"I hope that people with post-vaccination syndromes can be taken seriously," she said.

H.Pradhan--DT